These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

925 related items for PubMed ID: 27959420

  • 1. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J, Bi F, Yang Y, Zhang Y, Jin A, Li J, Lin Z.
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [Abstract] [Full Text] [Related]

  • 2. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J, Liu S, Xu Y, Wang C, Lin Z, Qin Y, Liu S.
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
    Liu C, Yang Z, Li D, Liu Z, Miao X, Yang L, Zou Q, Yuan Y.
    Cancer Biomark; 2015 Feb; 15(6):735-43. PubMed ID: 26406402
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH, Wang Y, Yang JY, Li J, Feng MX, Wang YH, Yang XM, He P, Tian GA, Zhang XX, Li Q, Cao XY, Huo YM, Yang MW, Fu XL, Li J, Liu DJ, Dai M, Wen SY, Gu JR, Hong J, Hua R, Zhang ZG, Sun YW.
    Oncotarget; 2016 Jan 26; 7(4):4226-40. PubMed ID: 26735172
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT, Fu XL, Li J, Bian YN, Liu DJ, Hua R, Ren LL, Li CT, Sun YW, Chen HY, Fang JY, Hong J.
    Oncotarget; 2015 Nov 10; 6(35):37028-42. PubMed ID: 26498693
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Wen Z, Liao Q, Zhao J, Hu Y, You L, Lu Z, Jia C, Wei Y, Zhao Y.
    Ann Surg Oncol; 2014 Jan 10; 21(1):125-32. PubMed ID: 24132627
    [Abstract] [Full Text] [Related]

  • 11. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X, Qi D, Qi J, Mao Z, Li X, Zhang J, Li J, Gao W.
    Oncol Rep; 2016 Jan 10; 35(1):155-62. PubMed ID: 26530274
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
    Wang L, Xiong L, Wu Z, Miao X, Liu Z, Li D, Zou Q, Yang Z.
    World J Surg Oncol; 2018 Jan 18; 16(1):11. PubMed ID: 29347944
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma.
    Zhang J, Jiang X, Zhang J.
    World J Surg Oncol; 2014 Mar 01; 12():49. PubMed ID: 24581082
    [Abstract] [Full Text] [Related]

  • 18. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.
    Suzuki K, Watanabe A, Araki K, Yokobori T, Harimoto N, Gantumur D, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Kubo N, Gombodorj N, Nishiyama M, Hosouchi Y, Kuwano H, Shirabe K.
    Anticancer Res; 2018 Feb 01; 38(2):939-944. PubMed ID: 29374725
    [Abstract] [Full Text] [Related]

  • 19. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
    Shi G, Dong M, Sheng W, Zhou J, Yu D, Sun W.
    Zhonghua Wai Ke Za Zhi; 2014 Oct 01; 52(10):781-6. PubMed ID: 25573220
    [Abstract] [Full Text] [Related]

  • 20. Annexin A2 and CD105 expression in pancreatic ductal adenocarcinoma is associated with tumor recurrence and prognosis.
    Huang YK, Liu H, Wang XZ, Zhu S.
    Asian Pac J Cancer Prev; 2014 Oct 01; 15(22):9921-6. PubMed ID: 25520129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.